FISDAP Airway, Ventilation, and Respiratory Practice Test

Administering bronchodilators often leads to tachycardia as a common side effect. This occurs because many bronchodilators, particularly beta-agonists, stimulate the beta-adrenergic receptors in the body. These receptors not only relax bronchial smooth muscle to help open the airways but also affect the cardiovascular system by increasing heart rate. The activation of these receptors can lead to an increase in the heart's workload and result in tachycardia, especially at higher doses or with certain formulations.

This characteristic makes tachycardia an important observation for healthcare providers when monitoring patients who are receiving bronchodilator therapy. Understanding this side effect is crucial for effectively managing patients with respiratory conditions since it can impact their overall cardiovascular status. The presence of increased heart rate may also necessitate further inquiry into the patient’s tolerance of the medication, particularly if they have pre-existing cardiac conditions.